Merck
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Merck and other ETFs, options, and stocks.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
MRK News
Pyxis Oncology (PYXS) announced preliminary data from the ongoing Phase 1 clinical dose escalation study evaluating PYX-201 in multiple types of solid tumors. P...
Johnson & Johnson (JNJ) and Merck (MRK) are cutting jobs in China as they face growing competition from domestic rivals resulting from Beijing’s campaign to dri...
Jefferies raised the firm’s price target on Merck (MRK) to $149 from $148 and keeps a Buy rating on the shares after subcutaneous administration of pembrolizuma...
Analyst ratings
78%
of 27 ratingsMore MRK News
Merck (NYSE:MRK) marked a major milestone in its bid to introduce a new formulation for its famous cancer therapy pembrolizumab on Tuesday as its blockbuster in...
Mark Kleinman, Sky News’ City editor, posted on X, the service formerly known as Twitter: “Revealed: Merck (MRK), the US-listed pharma group, is the latest indu...
On Tuesday, Merck & Co Inc MRK revealed topline results from the pivotal Phase 3 MK-3475A-D77 trial evaluating the noninferiority of subcutaneous administration...
The subdued stock price reaction suggests that Merck & Co., Inc.'s ( ) strong earnings didn't offer any surprises. Investors are probably missing some underlyin...
Wolfe Research initiated coverage of Merck (MRK) with a Peer Perform rating. The firm said the main sentiment driver for Merck is Gardasil’s outlook in China, a...
Merck (NYSE:MRK) and LaNova Medicines announced Thursday an agreement under which the U.S. pharmaceutical giant is expected to obtain licensing rights to a canc...